Lab21 announced that it has obtained a licence from Celera, an Applera Corporation business, to provide access to its test for cirrhosis risk in patients with chronic hepatitis C viral (HCV) infection in the UK and Ireland. The test, known as CRS7, is the first clinical test capable of pre ... more
Celera Genomics Receives NIH Grant to Develop and Commercialize Avian Flu Diagnostic Test
08-24-2006: Celera Genomics, an Applera Corporation business, announced that the National Institutes of Health (NIH) has awarded Celera approximately $900,000 to develop and commercialize an in vitro diagnostic (IVD) test for the highly pathogenic influenza A/H5 virus (Asian lineage, H5N1). The test Celera plans to develop will be based on the Primer and Probe Set and protocols used in the test from the U.S. Health and Human Services' Centers for Disease Control and Prevention (CDC) recently cleared by the U.S. Food and Drug Administration (FDA). According to the company, the CDC assay is the only FDA-cleared assay for detection of the H5N1 virus, and its use is limited to the laboratories designated by the Laboratory Response Network. Celera's access to the H5N1 assay information will be through a license to be obtained by Celera from the CDC. The test is expected to be sold through Celera's alliance with Abbott.
The grant will partially support a multi-phased, three year project. Performance testing and validation will be done in collaboration with the CDC, which has accumulated a large collection of influenza strains and clinical respiratory specimens as a World Health Organization (WHO) Collaborating Center for Surveillance, Epidemiology and Control of Influenza, as well as with other interested laboratories.
Facts, background information, dossiers
More about Celera Genomics
-
News
Celera Genomics Receives NIH Grant to Develop and Commercialize Avian Flu Diagnostic Test
Celera Genomics, an Applera Corporation business, announced that the National Institutes of Health (NIH) has awarded Celera approximately $900,000 to develop and commercialize an in vitro diagnostic (IVD) test for the highly pathogenic influenza A/H5 virus (Asian lineage, H5N1). The test Ce ... more
Celera and Collaborators Discover Genetic Markers Associated with Early-onset Heart Attacks
Celera Genomics, an Applera Corporation business, the University of California, San Francisco (UCSF), Cleveland Clinic, Case Western Reserve University and Brigham Young University, announced a publication describing two novel genetic markers associated with an increased risk for myocardial ... more
More about Applera
-
News
Applied Biosystems, 454 Life Sciences and Illumina Join 1000 Genomes Project
Leaders of the 1000 Genomes Project announced that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: Appl ... more
BIOTECON Diagnostics signs license agreement with Applera Corporation
Applera and BIOTECON Diagnostics (BCD) announced a non-exclusive, worldwide license agreement relating to PCR technology for Food Testing Applications and Genetically-Modified Organism (GMO) Testing Applications: BIOTECON Diagnostics has acquired important rights with the PCR licence. In ... more
Lab21 announced that it has obtained a licence from Celera, an Applera Corporation business, to provide access to its test for cirrhosis risk in patients with chronic hepatitis C viral (HCV) infection in the UK and Ireland. The test, known as CRS7, is the first clinical test capable of pre ... more
Most read news
- 1Sartorius grows at double-digit rates and boosts operating earnings by more than 30%
- 2Takara Bio Europe Goes Direct in 2012
- 3Thermo Fisher Scientific Awarded Patent for Cell Factory System
- 4Portable device will quickly detect pathogens in developing countries
- 5Dunn Labortechnik celebrates its 30th anniversary
- 6Guinness World Record: X-ray laser FLASH shoots fastest movie
- 7Schleicher & Schuell has been purchased by Whatman plc
- 8New technology allows scientists to watch cancer cells in action at unprecedented resolution
- 9Semiconductors for Cool Computers
- 10SCHOTT Instruments has changed its name to SI Analytics
- 1New analytical method for detecting the mineral oil contents in foodstuffs resulting from recycled cardboard
- 2Schleicher & Schuell has been purchased by Whatman plc
- 3Breakthrough in X-Ray Nanospectroscopy
- 4Agilent Technologies Completes Acquisition of BioSystem Development Business
- 5The world's fastest camera: Trillion-frame-per-second video
- 6SGS Minerals Services opens new lab in Chennai, India
- 7Danaher Announces Definitive Agreement to Acquire Leica Microsystems
- 8SCHOTT Instruments has changed its name to SI Analytics
- 9Sartorius opens new plant in India
- 10Genzyme Launches New Diagnostic Test for Common Blood Cancer
- 1The world's fastest camera: Trillion-frame-per-second video
- 2New analytical method for detecting the mineral oil contents in foodstuffs resulting from recycled cardboard
- 3Schleicher & Schuell has been purchased by Whatman plc
- 4SCHOTT Instruments has changed its name to SI Analytics
- 5Breakthrough in X-Ray Nanospectroscopy
- 6Abbott Receives CE Mark for New Hepatitis Test
- 7Sartorius opens new plant in India
- 8SGS Minerals Services opens new lab in Chennai, India
- 9Danaher Announces Definitive Agreement to Acquire Leica Microsystems
- 10Genzyme Launches New Diagnostic Test for Common Blood Cancer
News from research
- Sharp images from the living mouse brain
- Genes linked to cancer could be easier to detect with liquid lasers
- Pushing the Boundaries: New dye could open the door to in vivo applications ...
- Chemists develop faster, more efficient protein labeling
- New technology allows scientists to watch cancer cells in action at unpreced ...
Last viewed
- Applied Biosystems, 454 Life Sciences and Illumina Join 1000 Genomes Project - - Biotech Innovators Will Contribute to International Effort To Produce Most Detailed Map of Genetic Variation
- Inverness Medical verkündet Markteinführung des TECHLAB C. DIFF QUIK CHEK COMPLETE - - Der Schnelltest für die Diagnose von Clostridium difficile-Infektionen weist sowohl die gängigen Antigene als auch die Toxine A und B nach
- ECHA publishes an updated list of pre-registered substances -
- Olympus Opens Global Research and Development Centre in Munich -
- Warwick: GMP compliant analytical services -
